DISRUPTIVE BEHAVIOR DISORDER (DBD) MEDICATION MARKET ANALYSIS

Disruptive Behavior Disorder (DBD) Medication Market by Disease Type (Oppositional Defiant Disorder, Conduct Disorder, and Intermittent Explosive Disorder), by Medication Type (Stimulant, Antipsychotics, Alpha-Agonist, Anticonvulsant, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI2390
Formats :
Excel and PDF
Industry : Pharmaceutical

Disruptive Behavior Disorder (DBD) Medication MarketSize and Trends

Disruptive Behavior Disorder Medication Market - Market Dynamics

Major factors responsible for growth of the disruptive behavior disorder medication market are rising burden of the disruptive behavior disorders worldwide, increasing awareness amongst parent about this disorder, and improvement of psychotic and medication treatment. According to a study published in the journal BMJ Open (Matthew D Burkey et al) in 2015, oppositional defiant disorder (ODD) and conduct disorder (CD) had an estimated worldwide prevalence of 3.3% and 3.2%, respectively. World Health Organization in its 2016 factsheet stated that globally, 7.4 % of disability-adjusted life years (DALYs) are caused by disorders in mental and behavioral disorders category.